<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A mutation in the promoter of the <z:chebi fb="0" ids="17659">uridine diphosphate</z:chebi> glucuronosyltransferase gene has been described in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> from Northern Europe </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To assess the frequency of this mutation in Italian patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and in <z:mpath ids='MPATH_458'>normal</z:mpath> controls, in order to establish the molecular basis and molecular epidemiology of the syndrome in Italy </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS: Forty-six patients with a clinical diagnosis of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and 44 individuals from the general population unselected for <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Polymerase chain reaction amplification of the TATA-box element in the promoter of <z:chebi fb="0" ids="17659">uridine diphosphate</z:chebi> glucuronosyltransferase and identification of <z:mp ids='MP_0002169'>wild-type</z:mp> and variant alleles by high-resolution <z:chebi fb="0" ids="53656">polyacrylamide</z:chebi> gel electrophoresis </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A TATA-box variant in the promoter of <z:chebi fb="0" ids="17659">uridine diphosphate</z:chebi> glucuronosyltransferase was found on 93% of chromosomes from patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The same variant was present on 44% of chromosomes from controls, unselected for <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels </plain></SENT>
<SENT sid="6" pm="."><plain>Only 55% of controls homozygous for the TATA-box variant, however, had <z:hpo ids='HP_0003573'>increased bilirubin</z:hpo> levels </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The TATA-box variant in the promoter of <z:chebi fb="0" ids="17659">uridine diphosphate</z:chebi> glucuronosyltransferase is strongly associated with the phenotype of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> in Italy </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:hpo ids='HP_0003829'>incomplete penetrance</z:hpo> of the mutation observed in controls indicates that other acquired or inherited conditions affecting <z:chebi fb="0" ids="16990">bilirubin</z:chebi> production, uptake, cellular transport or excretion may contribute to the <z:e sem="disease" ids="C0020433" disease_type="Disease or Syndrome" abbrv="">hyperbilirubinaemia</z:e> of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
</text></document>